TAZ is downregulated by dexamethasone during the differentiation of 3T3-L1 preadipocytes

Biochemical and Biophysical Research Communications

Volumn 419, Issue 3, 2012, Pages 573-577

  He, Qun ^a   Huang, Hai Yan ^a,b   Zhang, You You ^b   Li, Xi ^a,b   Qian, Shu Wen ^b   Tang, Qi Qun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Adipocyte differentiation; Dexamethasone; TAZ; Trans differentiation

Indexed keywords

BETA ACTIN; BINDING PROTEIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; OSTEOCALCIN; TAZ PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; MITOSIS; NUCLEOTIDE SEQUENCE; OSTEOCYTE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; DEXAMETHASONE; DOWN-REGULATION; MICE; MITOSIS; OSTEOCYTES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84862800398     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.074     Document Type: Article

References (29)

1. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowitz M., Hisaminato A., Fujiwara T., Ito Y., Cantley L.C., Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000, 19:6778-6791.
2. Murakami M., Nakagawa M., Olson E.N., Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl. Acad. Sci. USA 2005, 102:18034-18039.
3. Di Palma T., D'Andrea B., Liguori G.L., Liguoro A., de Cristofaro T., Del Prete D., Pappalardo A., Mascia A., Zannini M. TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Exp. Cell Res. 2009, 315:162-175.
4. Varelas X., Sakuma R., Samavarchi-Tehrani P., Peerani R., Rao B.M., Dembowy J., Yaffe M.B., Zandstra P.W., Wrana J.L. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat. Cell Biol. 2008, 10:837-848.
5. Lei Q.Y., Zhang H., Zhao B., Zha Z.Y., Bai F., Pei X.H., Zhao S., Xiong Y., Guan K.L. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 2008, 28:2426-2436.
6. Cui C.B., Cooper L.F., Yang X., Karsenty G., Aukhil I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol. Cell. Biol. 2003, 23:1004-1013.
7. Hong J.H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., Yaffe M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-1078.
8. Murakami M., Tominaga J., Makita R., Uchijima Y., Kurihara Y., Nakagawa O., Asano T., Kurihara H. Transcriptional activity of Pax3 is co-activated by TAZ. Biochem. Biophys. Res. Commun. 2006, 339:533-539.
9. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
10. Caplan A.I., Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 2001, 7:259-264.
11. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
12. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., Spiegelman B.M., Mortensen R.M. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 1999, 4:611-617.
13. Rosen E.D., Walkey C.J., Puigserver P., Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev. 2000, 14:1293-1307.
14. Cornelius P., MacDougald O.A., Lane M.D. Regulation of adipocyte development. Annu. Rev. Nutr. 1994, 14:99-129.
15. Jorgensen N.R., Henriksen Z., Sorensen O.H., Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 2004, 69:219-226.
16. Eijken M., Koedam M., van Driel M., Buurman C.J., Pols H.A., van Leeuwen J.P. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell. Endocrinol. 2006, 248:87-93.
17. Liu Y., Porta A., Peng X., Gengaro K., Cunningham E.B., Li H., Dominguez L.A., Bellido T., Christakos S. Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k. J. Bone Miner. Res. 2004, 19:479-490.
18. Chen T.L. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 2004, 35:83-95.
19. Atmani H., Chappard D., Basle M.F. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J. Cell. Biochem. 2003, 89:364-372.
20. Luppen C.A., Smith E., Spevak L., Boskey A.L., Frenkel B. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J. Bone Miner. Res. 2003, 18:1186-1197.
21. Canalis E. Mechanisms of glucocorticoid action in bone. Curr. Osteoporos. Rep. 2005, 3:98-102.
22. Hong D., Chen H.X., Xue Y., Li D.M., Wan X.C., Ge R., Li J.C. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J. Steroid Biochem. Mol. Biol. 2009, 116:86-92.
23. Tang Q.Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:44-49.
24. Newton R. Molecular mechanisms of glucocorticoid action: what is important?. Thorax 2000, 55:603-613.
25. Beato M., Truss M., Chavez S. Control of transcription by steroid hormones. Ann. NY Acad. Sci. 1996, 784:93-123.
26. Beato M. Gene regulation by steroid hormones. Cell 1989, 56:335-344.
27. Tang Q.Q., Zhang J.W., Lane M.D. Sequential gene promoter interactions by C/EBPbβ, C/EBPα, and PPARγ during adipogenesis. Biochem. Bioph. Res. Co. 2004, 318:213-218.
28. Adcock I.M., Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 2001, 79:376-384.
29. Woolf A.D. An update on glucocorticoid-induced osteoporosis. Curr. Opin. Rheumatol. 2007, 19:370-375.